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Abstract
Background: Pulmonary function is often affected by the inhalation of metal particles. The resulting pathology
might trigger various lung diseases, e.g., parenchymal lung fibrosis and granulomatous lung disorders. We previously
demonstrated that 6 % of tissue-proven sarcoid patients had a positive beryllium lymphocyte proliferation test (BeLPT),
thus correcting the diagnosis to chronic beryllium disease. The aim of this study was to examine if MEmory Lymphocyte
Immnuno Stimulation Assay (MELISA®), currently used for non-pulmonary diseases, can identify metals other than
beryllium that can also trigger sensitization and induce granulomatous disease.
Methods: This pilot study included 13 sarcoid-like patients who underwent MELISA®. Eleven patients also underwent
BeLPT. Biopsy samples were tested for metal content by scanning electron microscope. Eleven study patients had been
exposed to metals at the workplace and 2 had silicone implants.
Results: Two patients who had undergone BeLPT were positive for beryllium. MELISA® detected 9 patients (9/13, 69 %)
who were positive for at least one of the tested metals: 4 reacted positively to nickel, 4 to titanium, 2 to chromium, 2
to beryllium, 2 to silica, and one each to palladium, mercury and lead.
Conclusion: It is proposed that MELISA® can be exploited to also identify specific sensitization in individuals exposed
to inhaled particles from a variety of metals.
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Background
Metals are known to cause a number of different patho-
logical conditions, including pulmonary disease [1, 2].
The inhalation of metal dust can cause a variety of lung
diseases, such as parenchymal lung fibrosis and granu-
lomatous lung disorders [3, 4]. Granulomatous inflam-
mation and hypersensitivity pneumonitis are associated
with the inhalation of metal dust and fumes as well as
with mycobacterial or fungal infections [4].
Increased industrial uses of beryllium and consequent
occupational beryllium exposure resulted in an epidemic
of chronic beryllium disease (CBD) in the United States
and other countries [5]. The delayed type hypersensitiv-
ity induced by beryllium serves as a model for immuno-
logically driven granulomatous lung disease [6, 7]. We
had previously demonstrated that 6 % of tissue-proven
sarcoid patients who had a positive beryllium lympho-
cyte proliferation test (BeLT) had been erroneously diag-
nosed as having sarcoidosis and not CBD [8]. The rate
of granulomatous lung disease in workers exposed to the
metals other than beryllium is unknown. Because of the
relative paucity of case reports on other metals, the inci-
dence might either be low or underreported.
It was recently shown that lymphocyte proliferation
tests can be useful in assessing occupational sensitization
[9]. Several case reports demonstrated increased
lymphocyte proliferation to titanium [10], aluminum
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[11, 12] chromium and nickel [13], the latter as a side ef-
fect following hip arthroplasty. MEmory Lymphocyte
Immnuno Stimulation Assay (MELISA®) is a lymphocyte
proliferation test currently used in the setting of non-
pulmonary diseases. We conducted a pilot study to de-
termine whether MELISA® is also effective in identifying
sensitization to a number of selected metals in a cohort
of exposed sarcoid patients with lung granulomatous
diseases who had been exposed to various substances at
the workplace and in the environment.
Methods
The study cohort was comprised of 13 sarcoid patients
who were referred to our Institute of Pulmonary and
Allergic Diseases to undergo occupational exposure as-
sessment. The characteristics of the patients are listed in
Table 1. Eleven patients had been exposed to toxic air-
borne substances at the workplace and two patients de-
veloped granulomatous diseases after ruptured silicone
implants (Table 1). Each participant filled in a question-
naire on demographic and occupational parameters and
a general health profile. They all underwent a lung bi-
opsy which confirmed the diagnosis of noncaseating
granulomas. Sarcoidosis was diagnosed by a clinical and
roentgenological evaluation or a positive transbronchial
biopsy. All subjects gave written informed consent to be
enrolled in this investigation, and the study was
approved by the Tel-Aviv Medical Center Institutional
Ethics Committee.
MELISA® is an optimized lymphocyte transformation
test that was described in depth elsewhere [14]. For the
current work, blood samples were drawn into tubes con-
taining citrate in the Tel Aviv lab and sent for analysis to
the MGD Laboratory in Geneva, Switzerland. The blood
was delivered by courier after overnight transport not
exceeding 24 h and at ambient temperature. The choice
of metals for testing was based on information derived
from the questionnaire, which was delivered to the la-
boratory together with the blood sample.
BeLPT was performed within 24 h of venipuncture
according the method of Mroz et al. [15]. Results were
Table 1 Patient characteristics
Number Gender Age (yrs) Exposure route
1 Male 70 Military industry
2 Male 61 Metal industry
3 Female 63 Jewelry industry
4 Male 58 Aviation industry
5 Male 70 Welding
6 Male 63 Welding
7 Male 63 Military industry
8 Male 45 Dental technician
9 Male 50 Dental technician
10 Female 40 Dental technician
11 Female 45 Teaching
12 Female 35 Silicone implants
13 Female 40 Silicone implants
Fig. 1 A representative analysis of lung tissue biopsy by SEM. a Particles containing Al, Si, and Fe. b Particles containing Ni, Si, Fe, and Cr
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expressed as a stimulation index (SI), which is the ratio
of the counts per minute of radioactivity in cells stimu-
lated with beryllium salts divided by the counts per
minute for un-stimulated cells. The normal ranges for
the SI are laboratory-dependent and based on the mean
peak SI plus 3 standard deviations for unexposed sub-
jects. SIs higher than those values were considered as a
positive response to beryllium. To fulfill the criteria
for a positive beryllium-specific response, at least two
or more elevated SIs occurring at any of the BeSO4
concentrations tested must have been present. An SI
>2.5 was considered elevated.
Mineralogical studies were performed on the paraffin
block of the lung biopsy. A sample from a paraffin block
was processed for electron microscopic studies by em-
bedding it in Epon. Thin sections were cut and lightly
contrasted by uranyl acetate The chemical composition
of selected specimens was investigated by counting 500
particles (>0.8 μm in diameter) by X-ray analysis using a
JEOL 840 scanning electron microscope (SEM) equipped
with a Link 10,000 energy-dispersive system (EDS). The
spectrometer of the EDS system separates the elements
according to energy rather than wavelength. A petro-
graphic microscope was also used to identify the
minerals. A representative SEM analysis of the lung
tissue biopsy of patient #2 (Fig. 1).
Results
A total of 13 sarcoid patients were enrolled in this pilot
study. MELISA® was targeted to identify specific metals
according to their occupational questionnaire and type
of exposure. SEM was performed in lung biopsies and
showed noncaseating granulomas in 12/13 patients. All
the exposed workers but not the silicone implanted
women also underwent BeLPT. The tested metals and
the test results are shown in Table 2.
MELISA® detected 9 patients (9/13, 69 %) who were
positive for at least one of the tested metals: 4 reacted
positively to nickel, 4 to titanium, 2 to chromium, 2 to
beryllium, 2 to silica, and one each to palladium, mer-
cury and lead. Both patients who developed lung gra-
nulomatous disease following the rupture of silicone
implants had a positive MELISA® result to nickel (Table 2).
A representative report for a MELISA® evaluation is
shown in Fig. 2.
BeLPT detected two of the 13 patients as being posi-
tive to beryllium and 11 as being negative. Seven of the
11 BeLPT-negative patients (63.6 %) were positive for at
least one of the tested metals. Three of the 11
workplace-exposed patients were dental technicians and
they were exposed to many metals used in dentistry, but
only one of them responded positively to chrome, nickel
and beryllium. One of the remaining two was negative
to all tested metals and the other responded positively to
beryllium only on the Be-LPT evaluation.
Discussion
Accurate diagnosis of sarcoidosis requires a careful
inquiry about any potential exposure to both organic
and inorganic allergens. Several epidemiologic investi-
gations have suggested that it is an occupational or
infectious (e.g., viruses, Borrelia burdorfori, and Propi-
onibacterium acnes) [16] clustering disease. The fact
that sarcoidosis generally develops in early adulthood
suggests that both infectious and noninfectious causa-
tive exposures occur in working-age individuals as they
Table 2 Results of scanning electron microscopy (SEM), the beryllium lymphocyte proliferation test BeLPT and MELISA®
Pt. Diagnosis Metals tested by SEM Metals tested by MELISA® MeLPT BeLPT Exposure route
1 SA; NCG (+) Fe, Ti, Al, Si Al, Si, Ti (-) Be(-) Military industry
2 SA; NCG (+) Si, Cr, Ni, Fe Cr, Fe, Ni, Si, Ti, Be Ti(+) Be(-) Metalworks
3 SA; NCG (+) Si, Cr, Ni, Fe, Mo Cr, Au, Hg, Pa, Ti, Ni, Mo Ti(+) Pa(+) Be(-) Jewelry industry
4 SA; NCG (+) Au, Zn, Si, Al, Al, Au, Hg, Pa, Si, Ti, Zn, Be Hg(+) Be(-) Aviation industry
5 SA; NCG (−) Al, Ag, Cu Ag, Cu, Al (-) Be(-) Welding
6 SA; NCG (+) Al, Si, Fe, Zn Hg, Ni, Si, Ti, Zn, Pb, Ti Ti(+) Pb(+) Be(-) Welding
7 SA; NCG (+) Al, Si Fe Al, Au, Fe, Si, Ti, Be Ti(+) Be(+) Be(-) Military industry
8 CBD NCG (+) (−) Fe, Ni, Ti, Be (-) Be(+) Dental technician
9 CBD NCG (+) Al, Si Cr, Fe, Ni Al, Cr, Fe, Ni, Si, Be Si(+)Fe (+)Cr(+) Ni(+) Be(+) Be(+) Dental technician
10 SA; NCG (+) Si, Cr, Co, Fe, Ti, Ni, W, Mn Cr, Co, Fe, Mn, Ni, Si, Ti, (-) Be(-) Dental technician
11 SA; NCG (+) Fe, Cr, Ni, Si Cr, Hg, Fe, Ni, Si, Ag, Sn Si(+)Cr(+) Ni(+) Be(-) Teacher
12 SA; NCG (+) Si, Au, Cr, Fe Au, Hg, Ni, Pa, Pl, Si Ni(+) ND Silicone implants
13 SA; NCG (+) Si Au, Ni, Pa, Pl, Si Ni(+) ND Silicone implants
Pt patient #, SA sarcoidosis, NCG non-caseating granulomas, ND not done, Al aluminum, Cu copper, Si silica, Fe iron, Ti titanium, Cr chrome, Ni nickel, Au gold,
Mo molybdenum, Zn zinc, Hg mercury, Mn manganese, Co cobalt, Pb lead, W tungsten, Pa palladium
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Fig. 2 A representative report of MELISA®. a Positive control (PWM, popweed mitogen) and negative results for Cr, Fe, Ni and Si but positive for Ti.
b Negative results for Cr, Fe, Ni and Si but positive for Ti
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enter the workforce [17]. Other studies have postulated
that exposure to granuloma-inducing allergens at the
workplace may cause sarcoidosis. For example, a clus-
tering of cases was detected in communities with lum-
bering or wood milling as the principal local industry
[18]. Others have found clustering of cases among
mechanics, postal workers [18], firefighters [19] and
healthcare workers [20].
We were the first to document a case of CBD in Israel
in a dental technician who was first diagnosed as having
sarcoidosis [21]. The comprehensive environmental an-
amnesis was instrumental in correcting the diagnosis to
CBD. Motivated by this case, we performed a prospect-
ive study and recalled patients from our outpatient clinic
who had been diagnosed as having sarcoidosis. We ree-
valuated their occupational exposure history and found
that 3/47 patients (6 % of all patients diagnosed with sar-
coidosis) with a positive occupational exposure to beryl-
lium and a positive BeLPT had CBD and had been
misdiagnosed as having sarcoidosis.8 These results
emphasize the vital importance of taking an occupa-
tional history together with administering the BeLPT,
the cornerstone of both medical surveillance and diag-
nosis of beryllium sensitization and disease. In the same
context there is a need to take occupational history to
other type of exposures and to include other lympho-
cyte proliferation tests to other metals other than ber-
yllium. Sensitizers and other case reports had been
published showed increased lymphocyte proliferation in
response to titanium [10], aluminum [11, 12], chrome
and nickel [13].
To the best of our knowledge, this is the first report on
patients with biopsy-proven granulomatous disease in
whom deposition of metals in the lungs was demonstrated
by evidence of multiple metal sensitization on MELISA®
simultaneously with the SEM analysis. The metals were
chosen for testing according to occupational history, the
responses to an overall metal exposure questionnaire, and
the metals identified in the lung tissue biopsy.
We did not find a good correlation between SEM
metal analysis and the results of lymphocyte prolifera-
tion testing may be due to the fact that the analysis is
done randomly on 3–4 places on the biopsy surface [22],
and either does not represent the total content of the
metals in the tissue or there is an insufficient concentra-
tion of metal for detection with SEM [23]. Another
explanation is that may be that like for beryllium CD4 T
cell responding in the blood is determined by the rela-
tive proportion of memory T cell subsets, which is influ-
enced by the degree of target organ inflammation [24].
Moreover, it was recently shown that anti-HLA-DP and
anti-LFA-1 antibodies are present in individuals with
sensitization to beryllium and that they may eliminate
proliferation ability and cytokine production [25].
On the other hand, we had demonstrated a very strong
response to beryllium in the BeLPT test of a patient with
post-traumatic shrapnel deposited in the chest wall. The
concentration of beryllium in the shrapnel was very low:
it was undetectable by SEM and only detected by ion
mass spectrometry [26]. Similarly, Stejskal recently re-
ported that a very low concentration of beryllium in the
gold crown of a tooth of a fibromyalgia patient induced
a strong MELISA®-positive reaction to beryllium [27].
It was concluded that the most frequent metals that
cause granulomatous disease, such as aluminum, barium,
cobalt, copper, gold, nickel, titanium, and zirconium,
should be tested by a widely applicable and sensitive
lymphocyte proliferation test, such as MELISA®, in sar-
coid patients who are exposed to metals at the work-
place. Other metals for evaluation should be selected
from the individual’s occupational and environmental
exposure history. Some metals, such as aluminium, silica
and mercury, might play a dual role in inflammatory re-
actions: in addition to their function as antigens, they
also have immunomodulatory properties and act as
adjuvants in increasing the immune response to others
inhaled metals.
Conclusions
In conclusion, results of this pilot study serve to
emphasize the vital importance of taking a comprehen-
sive occupational history in the clinical evaluation of
patients suspected of having sarcoidosis.
The rate of granulomatous lung disease in workers ex-
posed to the metals other than beryllium is unknown.
Because of the relative paucity of case reports on metals
other than beryllium, the incidence might either be
underreported. Identification of metal sensitization in
sarcoid-like metal-exposed patients by the MELISA®
lymphocyte proliferation test may have a crucial role to
avoid misdiagnosis in this population.
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